MedTrace Logo

Remote Monitoring in Cancer Care: A Platform Study

NCT05018208 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-10-30

No results posted yet for this study

Summary

This study investigates a device that closely monitors vital signs, as well as a smartphone application (app) that allows patients to respond to different questions and tests that will monitor for new symptoms. This study may help researchers understand if wearing the device is a better tool than standard vital sign assessment tools done only while at the doctor's office or hospital, and if using the smartphone app is a better tool than standard assessment tools used while in the doctor's office or hospital.

Conditions

  • Head and Neck Carcinoma
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Lung Carcinoma
  • Malignant Digestive System Neoplasm
  • Malignant Solid Neoplasm

Interventions

OTHER

Computer-Assisted Intervention

Use smartphone app

PROCEDURE

Patient Monitoring

Wear Biofourmis wearable device(s)

OTHER

Questionnaire Administration

Complete questionnaires

Sponsors & Collaborators

Principal Investigators

  • Jonas Paludo, M.D. · Mayo Clinic in Rochester

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-15
Primary Completion
2025-04-17
Completion
2025-04-17
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05018208 on ClinicalTrials.gov